Tissue Therapy of Transsphincteric Anal Fistula
ConditionAnal Fistula
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Southern Denmark
About this trial
This clinical study aims to evaluate the outcome of the treatment of complex perianal fistulas (PAF) by the combination of minimal surgical debridement with regenerative cellular therapeutics.
Eligibility criteria
Qualifiers
able to communicate with Danish language
able to provide informed consent
having address in the region of southern Denmark during the study
Disqualifiers
Signs of suppuration/cavitation around the fistula
Simple or low anal fistula, which can be treated by simple surgical incision
Ano-vaginal and recto-vaginal fistula
The presence of more than one fistula tract, more than two external orifices or more than one internal orifice
Trial design
Treatments tested in this trial
- ADRC injection
- ADRC001 injection
Treatment groups
75 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov